Marijke van Walsum

468 total citations
16 papers, 388 citations indexed

About

Marijke van Walsum is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marijke van Walsum has authored 16 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marijke van Walsum's work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Biochemical and Molecular Research (4 papers). Marijke van Walsum is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Biochemical and Molecular Research (4 papers). Marijke van Walsum collaborates with scholars based in Netherlands. Marijke van Walsum's co-authors include Guus A.M.S. van Dongen, Dennis Verzijl, Martine J. Smit, David Maussang, Jens Holl, Detlef Michel, Rob Leurs, Olivier Pleskoff, Martijn Gerretsen and Jasper J. Quak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuroscience and British Journal of Cancer.

In The Last Decade

Marijke van Walsum

16 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marijke van Walsum Netherlands 10 162 140 130 90 82 16 388
Yasuhisa Imai Japan 8 138 0.9× 59 0.4× 200 1.5× 321 3.6× 53 0.6× 12 614
T Nakano Japan 12 119 0.7× 19 0.1× 179 1.4× 217 2.4× 89 1.1× 20 477
Chris A. Learn United States 7 311 1.9× 209 1.5× 183 1.4× 246 2.7× 38 0.5× 9 716
S. Staibano Italy 13 174 1.1× 49 0.3× 339 2.6× 54 0.6× 14 0.2× 25 548
W Knapp Austria 11 53 0.3× 43 0.3× 126 1.0× 205 2.3× 68 0.8× 21 407
Élise Héon Canada 17 105 0.6× 73 0.5× 333 2.6× 23 0.3× 158 1.9× 33 807
Massimiliano Dall’Ora Italy 10 213 1.3× 55 0.4× 140 1.1× 89 1.0× 32 0.4× 15 361
Cristina Capuano Italy 17 218 1.3× 49 0.3× 127 1.0× 527 5.9× 48 0.6× 30 727
K.R. Van Quill United States 7 92 0.6× 38 0.3× 191 1.5× 25 0.3× 48 0.6× 9 402
Michael L. Basara United States 6 81 0.5× 86 0.6× 116 0.9× 23 0.3× 53 0.6× 11 406

Countries citing papers authored by Marijke van Walsum

Since Specialization
Citations

This map shows the geographic impact of Marijke van Walsum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke van Walsum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke van Walsum more than expected).

Fields of papers citing papers by Marijke van Walsum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke van Walsum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke van Walsum. The network helps show where Marijke van Walsum may publish in the future.

Co-authorship network of co-authors of Marijke van Walsum

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke van Walsum. A scholar is included among the top collaborators of Marijke van Walsum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke van Walsum. Marijke van Walsum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Maussang, David, Dennis Verzijl, Marijke van Walsum, et al.. (2006). Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proceedings of the National Academy of Sciences. 103(35). 13068–13073. 177 indexed citations
2.
Brakenhoff, Ruud H., et al.. (1995). Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer. Cancer Immunology Immunotherapy. 40(3). 191–200. 2 indexed citations
3.
Brakenhoff, Ruud H., et al.. (1995). Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer. Cancer Immunology Immunotherapy. 40(3). 191–200. 18 indexed citations
4.
Gerretsen, Martijn, Gerard W.M. Visser, Ruud H. Brakenhoff, et al.. (1994). Complete ablation of small squamous cell carcinoma xenografts with186Re-labeled monoclonal antibody E48. Cell Biochemistry and Biophysics. 24-25(1-3). 135–142. 15 indexed citations
5.
Gerretsen, Martijn, et al.. (1992). Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG. British Journal of Cancer. 66(3). 496–502. 19 indexed citations
6.
Schrijvers, A. H. G. J., Martijn Gerretsen, Marijke van Walsum, et al.. (1992). Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984. Cancer Immunology Immunotherapy. 34(4). 252–258. 8 indexed citations
7.
Schrijvers, A. H. G. J., Martijn Gerretsen, Marijke van Walsum, et al.. (1991). Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Experimental Cell Research. 196(2). 264–269. 32 indexed citations
9.
Dongen, Guus A.M.S. van, et al.. (1990). Antitumor activity of brequinar sodium (Dup-785) against human head and neck squanmous cell carcinoma xenografts. Cancer Letters. 49(2). 133–137. 10 indexed citations
10.
Braakhuis, Boudewijn J.M., et al.. (1990). Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.. PubMed. 9(6). 1549–52. 5 indexed citations
11.
Braakhuis, Boudewijn J.M., et al.. (1989). Transplantability of Human Head and Neck Squamous Cell Carcinomas in Athymic Nude Mice. Archives of Otolaryngology - Head and Neck Surgery. 115(9). 1076–1078. 7 indexed citations
12.
Braakhuis, Boudewijn J.M., et al.. (1989). Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice. Head & Neck. 11(6). 511–515. 18 indexed citations
13.
Peters, Godefridus J., et al.. (1989). Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes. British Journal of Cancer. 59(3). 327–334. 33 indexed citations
14.
Visser, Gerard W.M., et al.. (1989). The in vitro and in vivo behaviour of 18F-labelled 5-fluoro-5,6-dihydrouracil nucleosides. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(4). 351–357. 3 indexed citations
15.
Braakhuis, Boudewijn J.M., Guus AMS van Dongen, Marijke van Walsum, A. Leyva, & G. B. Snow. (1988). Preclinical antitumor activity of 5-aza-2′-deoxycytidine agains human head and neck cancer xenografts. Investigational New Drugs. 6(4). 299–304. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026